Beyond animal models: revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and bioprinting

被引:0
|
作者
Prajakta Teli
Vaijayanti Kale
Anuradha Vaidya
机构
[1] Symbiosis School of Biological Sciences,Symbiosis International (Deemed University)
[2] Symbiosis Center for Stem Cell Research,Symbiosis International (Deemed University)
来源
Cell and Tissue Research | 2023年 / 394卷
关键词
Neurodegenerative disease; In vitro models; Organoids; Organ-on-a-chip; 3D bioprinting;
D O I
暂无
中图分类号
学科分类号
摘要
Neurodegenerative diseases (NDs) are characterized by uncontrolled loss of neuronal cells leading to a progressive deterioration of brain functions. The transition rate of numerous neuroprotective drugs against Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and Huntington’s disease, leading to FDA approval, is only 8–14% in the last two decades. Thus, in spite of encouraging preclinical results, these drugs have failed in human clinical trials, demonstrating that traditional cell cultures and animal models cannot accurately replicate human pathophysiology. Hence, in vitro three-dimensional (3D) models have been developed to bridge the gap between human and animal studies. Such technological advancements in 3D culture systems, such as human-induced pluripotent stem cell (iPSC)-derived cells/organoids, organ-on-a-chip technique, and 3D bioprinting, have aided our understanding of the pathophysiology and underlying mechanisms of human NDs. Despite these recent advances, we still lack a 3D model that recapitulates all the key aspects of NDs, thus making it difficult to study the ND’s etiology in-depth. Hence in this review, we propose developing a combinatorial approach that allows the integration of patient-derived iPSCs/organoids with 3D bioprinting and organ-on-a-chip technique as it would encompass the neuronal cells along with their niche. Such a 3D combinatorial approach would characterize pathological processes thoroughly, making them better suited for high-throughput drug screening and developing effective novel therapeutics targeting NDs.
引用
收藏
页码:75 / 91
页数:16
相关论文
共 14 条
  • [1] Beyond animal models: revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and bioprinting
    Teli, Prajakta
    Kale, Vaijayanti
    Vaidya, Anuradha
    CELL AND TISSUE RESEARCH, 2023, 394 (01) : 75 - 91
  • [2] 3D bioprinting for organ and organoid models and disease modeling
    Juraski, Amanda C.
    Sharma, Sonali
    Sparanese, Sydney
    da Silva, Victor A.
    Wong, Julie
    Laksman, Zachary
    Flannigan, Ryan
    Rohani, Leili
    Willerth, Stephanie M.
    EXPERT OPINION ON DRUG DISCOVERY, 2023, 18 (09) : 1043 - 1059
  • [3] In Vitro 3D Modeling of Neurodegenerative Diseases
    Louit, Aurelie
    Galbraith, Todd
    Berthod, Francois
    BIOENGINEERING-BASEL, 2023, 10 (01):
  • [4] Airflow-Assisted 3D Bioprinting of Human Heterogeneous Microspheroidal Organoids with Microfluidic Nozzle
    Zhao, Haiming
    Chen, Yishan
    Shao, Lei
    Xie, Mingjun
    Nie, Jing
    Qiu, Jingjiang
    Zhao, Peng
    Ramezani, Hamed
    Fu, Jianzhong
    Ouyang, Hongwei
    He, Yong
    SMALL, 2018, 14 (39)
  • [5] 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor-on-a-Chip
    Li, Wenxiu
    Zhou, Zhihang
    Zhou, Xiaoyu
    Khoo, Bee Luan
    Gunawan, Renardi
    Chin, Y. Rebecca
    Zhang, Liang
    Yi, Changqing
    Guan, Xinyuan
    Yang, Mengsu
    ADVANCED HEALTHCARE MATERIALS, 2023, 12 (18)
  • [6] In Vitro Human Joint Models Combining Advanced 3D Cell Culture and Cutting-Edge 3D Bioprinting Technologies
    Jorgensen, Christian
    Simon, Matthieu
    CELLS, 2021, 10 (03) : 1 - 8
  • [7] Current strategies using 3D organoids to establish in vitro maternal-embryonic interaction
    Saadeldin, Islam Mohamed
    Ehab, Seif
    Noreldin, Ahmed Elsayed
    Swelum, Ayman Abdel-Aziz
    Bang, Seonggyu
    Kim, Hyejin
    Yoon, Ki Young
    Lee, Sanghoon
    Cho, Jongki
    JOURNAL OF VETERINARY SCIENCE, 2024, 25 (03)
  • [8] Revolutionizing liver fibrosis research: the promise of 3D organoid models in understanding and treating chronic liver disease
    Navik, Umashanker
    Singh, Sumeet Kumar
    Khurana, Amit
    Weiskirchen, Ralf
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 19 (02) : 105 - 110
  • [9] Learning Interpretable Regularized Ordinal Models from 3D Mesh Data for Neurodegenerative Disease Staging
    Zhao, Yuji
    Laansma, Max A.
    van Heese, Eva M.
    Owens-Walton, Conor
    Parkes, Laura M.
    Debove, Ines
    Rummel, Christian
    Wiest, Roland
    Cendes, Fernando
    Guimaraes, Rachel
    Yasuda, Clarissa Lin
    Wang, Jiun-Jie
    Anderson, Tim J.
    Dalrymple-Alford, John C.
    Melzer, Tracy R.
    Pitcher, Toni L.
    Schmidt, Reinhold
    Schwingenschuh, Petra
    Garraux, Gaetan
    Rango, Mario
    Squarcina, Letizia
    Al-Bachari, Sarah
    Emsley, Hedley C. A.
    Klein, Johannes C.
    Mackay, Clare E.
    Dirkx, Michiel F.
    Helmich, Rick
    Assogna, Francesca
    Piras, Fabrizio
    Bright, Joanna K.
    Spalletta, Gianfranco
    Poston, Kathleen
    Lochner, Christine
    McMillan, Corey T.
    Weintraub, Daniel
    Druzgal, Jason
    Newman, Benjamin
    Van den Heuvel, Odile A.
    Jahanshad, Neda
    Thompson, Paul M.
    Van der Werf, Ysbrand D.
    Gutman, Boris
    MACHINE LEARNING IN CLINICAL NEUROIMAGING, MLCN 2022, 2022, 13596 : 115 - 124
  • [10] The Evolution of Anticancer 3D In Vitro Models: The Potential Role of Machine Learning and AI in the Next Generation of Animal-Free Experiments
    Momoli, Carolina
    Costa, Beatrice
    Lenti, Lorenzo
    Tubertini, Matilde
    Parenti, Marco Daniele
    Martella, Elisa
    Varchi, Greta
    Ferroni, Claudia
    CANCERS, 2025, 17 (04)